Nanfeng Corporation(300004)
Search documents
南风股份(300004) - 2025 Q1 - 季度财报
2025-04-25 15:10
Financial Performance - The company's operating revenue for Q1 2025 was CNY 136,313,593.53, representing a 21.85% increase compared to CNY 111,872,083.98 in the same period last year[5]. - Net profit attributable to shareholders increased by 44.38% to CNY 16,238,442.39 from CNY 11,246,776.97 year-on-year[5]. - The company's operating profit for the current period is 18,750,809.47, compared to 12,943,152.60 in the previous period, representing an increase of approximately 45.5%[21]. - The net profit attributable to the parent company is 16,238,442.39, up from 11,246,776.97 in the previous period, reflecting a growth of about 44.5%[22]. - The total comprehensive income for the current period is 16,238,442.39, compared to 10,954,624.37 in the previous period, reflecting a growth of approximately 48.5%[22]. Cash Flow and Investments - The net cash flow from operating activities improved significantly, reaching CNY 21,632,949.47, a 164.62% increase from a negative CNY 33,479,727.03 in the previous year[5]. - The total cash inflow from operating activities is 116,088,383.52, which is a substantial increase from 68,463,503.30 in the previous period[23]. - The company reported a net cash outflow from investing activities of -416,886,248.15, compared to -351,094,761.58 in the previous period, indicating increased investment activity[24]. - The company has received cash related to investment activities amounting to 10,000,000.00 in the current period, indicating ongoing investment efforts[24]. Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,094,843,071.11, a slight increase of 0.54% from CNY 2,083,584,262.62 at the end of the previous year[5]. - Total liabilities decreased to ¥332,271,341.92 from ¥337,250,972.82, a decline of about 1.4%[19]. - The company's total equity increased to ¥1,762,571,729.19 from ¥1,746,333,289.80, reflecting a growth of approximately 0.9%[19]. Expenses - Research and development expenses rose by 79.30% compared to the previous year, indicating increased investment in innovation[8]. - The company's financial expenses increased by 92.49% year-on-year, mainly due to a decrease in interest income[8]. - Total operating costs amounted to ¥121,584,877.64, up from ¥97,017,848.72, reflecting a 25% increase[20]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,860[14]. - The company’s basic earnings per share rose to CNY 0.03, a 50.00% increase from CNY 0.02 in the same period last year[5]. - Basic and diluted earnings per share for the current period are both 0.03, compared to 0.02 in the previous period, marking a 50% increase[22]. Other Financial Metrics - The weighted average return on equity increased to 0.93% from 0.66% year-on-year[5]. - The company reported a 701.42% increase in non-operating income, primarily due to customer compensation received[8]. - The company's cash and cash equivalents decreased to ¥128,694,368.22 from ¥529,448,835.41, a decline of approximately 76%[16]. - Accounts receivable rose to ¥476,467,356.63 from ¥463,467,447.57, indicating a slight increase of 3%[17]. - Inventory decreased to ¥142,115,576.55 from ¥170,902,714.25, a reduction of about 17%[17]. - The net loss for the current period was reported at ¥-1,045,123,042.01, an improvement from ¥-1,061,361,484.40 in the previous period[19].
今日271只个股突破五日均线
Zheng Quan Shi Bao Wang· 2025-04-24 07:56
Market Overview - The Shanghai Composite Index closed at 3297.29 points, above the five-day moving average, with a slight increase of 0.03% [1] - The total trading volume of A-shares reached 1,138.919 billion yuan [1] Stocks Performance - A total of 271 A-shares have surpassed the five-day moving average today [1] - Notable stocks with significant deviation rates include: - Jinkai Biological (金凯生科) with a deviation rate of 13.09% and a daily increase of 20.02% [1] - Lusi Co., Ltd. (路斯股份) with a deviation rate of 8.64% and a daily increase of 14.74% [1] - Ketaobiotechnology (科拓生物) with a deviation rate of 8.31% and a daily increase of 11.58% [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that just crossed the five-day moving average include: - Daychen Co., Ltd. (日辰股份) [1] - YTO Express (圆通速递) [1] - Jiama Clothing (嘉曼服饰) [1]
南风股份(300004) - 关于董事辞职的公告
2025-03-21 08:56
南方风机股份有限公司(以下简称"公司")于 2025 年 3 月 20 日收到公司 董事何万可先生的书面辞职报告。何万可先生因工作岗位调整的原因,申请辞去 公司第六届董事会董事职务(原定任期自 2023 年 9 月 15 日至 2026 年 9 月 14 日),同时辞去董事会审计委员会委员职务。辞去以上职务后,何万可先生不再 担任公司任何职务。截止本公告披露日,何万可先生未持有公司股份。 根据相关规定,何万可先生的辞职报告自送达董事会之日起生效。何万可先 生的辞职不会导致公司董事会人数低于法定最低人数,不会对董事会正常运作和 公司日常经营产生不利影响。公司将根据有关规定,尽快完成公司董事选举及后 续相关工作。 何万可先生在任职期间,恪尽职守、勤勉尽责,公司及董事会对何万可先生 任职期间为公司所做的贡献表示衷心感谢! 证券代码:300004 证券简称:南风股份 公告编号:2025-003 南方风机股份有限公司 关于董事辞职的公告 本公司及其董事会全体成员保证公告内容真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 南方风机股份有限公司 董事会 二〇二五年三月二十一日 1 特此公告。 ...
南风股份(300004) - 关于子公司完成工商变更登记的公告
2025-02-07 08:22
证券代码:300004 证券简称:南风股份 公告编号:2025-002 南方风机股份有限公司 名称:南方增材科技有限公司 关于子公司完成工商变更登记的公告 本公司及其董事会全体成员保证公告内容真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 南方风机股份有限公司(以下简称"公司")于 2024 年 12 月 31 日召开第 六届董事会第七次会议,审议通过了《关于收购子公司南方增材科技有限公司少 数股东权益并对其增资的议案》,具体内容详见公司于 2024 年 12 月 31 日公布 在中国证监会指定创业板信息披露网站巨潮资讯网的《关于收购控股子公司少数 股东权益并对其增资的公告》。 近日,南方增材完成了工商变更登记手续,并取得了佛山市南海区市场监督 管理局换发的营业执照,相关情况如下: 统一社会信用代码:91440605730450396R 类型:有限责任公司(自然人投资或控股的法人独资) 法定代表人:袁学亮 住所:佛山市南海区狮山镇小塘城区三环西路 31 号 F 车间 注册资本:13,000 万元人民币 经营范围:一般项目:技术服务、技术开发、技术咨询、技术交流、技术转 让、技术推广;增材制造;增材制 ...
南风股份(300004) - 2024 Q4 - 年度业绩预告
2025-01-23 08:06
Financial Performance Expectations - The company expects a net profit attributable to shareholders of approximately 60 million to 90 million yuan for the year 2024, compared to a loss of 21.04 million yuan in the same period last year[2] - The net profit after deducting non-recurring gains and losses is expected to be approximately 45 million to 75 million yuan, compared to a loss of 29.18 million yuan in the previous year[2] Factors Contributing to Performance Improvement - The improvement in performance is attributed to better execution of business orders and an increase in product gross margin[4] - The impact of asset impairment losses on the company's performance has decreased compared to the same period last year[4] - The estimated impact of non-recurring gains and losses on net profit is approximately 15 million yuan[4]
南风股份:拟1元收购南方增材49%股权并增资5000万元
Cai Lian She· 2024-12-31 10:35AI Processing
财联社12月31日电,南风股份公告称,为抓住3D打印、核电等行业快速发展的市场契机,公司拟以1元 价格收购张绣珠持有的南方增材35%股权、深圳大道持有的南方增材10%股权、杨志明持有的南方增材 4%股权,合计49%股权,并承担上述股东应缴未缴的出资义务;同时以自有资金5000万元人民币向南 方增材进行增资。 本次收购及增资完成后,公司将全力支持南方增材拓展3D打印服务及核电备品备件集采业务,增强其 在核电、消费、汽车、军工、航空航天等行业的市场影响力,改善南方增材经营状况,提升公司整体盈 利能力。 ...
南风股份:关于收到中标通知书的公告
2024-10-29 08:13
证券代码:300004 证券简称:南风股份 公告编号:2024-024 南方风机股份有限公司 本公司及其董事会全体成员保证公告内容真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 南方风机股份有限公司(以下简称"公司")于近日收到中广核工程有限公 司发出的中标通知书,公司被确认为"CS 项目 LOT150Ah 非安全级风阀、抗冲 击波龙卷风阀、防火阀及排烟阀"的中标方。现将具体情况说明如下: 一、中标项目主要内容 1、招标项目名称:CS 项目 LOT150Ah 非安全级风阀、抗冲击波龙卷风阀、 防火阀及排烟阀 2、招标方:中广核工程有限公司 3、中标人:南方风机股份有限公司 4、中标金额:人民币 5,987 万元 5、设备名称:非安全级风阀、抗冲击波龙卷风阀、防火阀及排烟阀设备, 包括设备的设计、制造、清洁、包装、运输、文件、消耗品、专用工具和现场技 术支持服务等,具体以招标文件规定为准。 关于收到中标通知书的公告 注册资本:388,600 万元人民币 住所:深圳市龙岗区宝龙街道宝龙社区宝龙三路 18 号中广核工程大厦 1 栋 A 座 4001 经营范围: 软件和信息技术、工程建设技术、质检技术的服务 ...
南风股份(300004) - 2024 Q3 - 季度财报
2024-10-24 10:02
Revenue and Profitability - Revenue for Q3 2024 reached ¥151,639,024.26, an increase of 47.49% year-over-year, and cumulative revenue for the year-to-date is ¥420,701,915.71, up 63.84% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was ¥20,841,050.91, a significant increase of 437.49% year-over-year, with year-to-date net profit reaching ¥41,966,162.57, up 451.35%[2] - The net profit excluding non-recurring items for Q3 2024 was ¥18,222,167.54, reflecting a 517.13% increase year-over-year, while year-to-date figures show a 643.02% increase to ¥31,184,388.93[2] - Basic earnings per share for Q3 2024 were ¥0.05, up 400.00% year-over-year, with diluted earnings per share also at ¥0.05, reflecting the same percentage increase[2] - Operating profit for Q3 2024 was CNY 45,876,520.01, up from CNY 5,357,620.78 in Q3 2023, indicating a substantial improvement in profitability[14] - Net profit for Q3 2024 was CNY 40,510,697.19, compared to CNY 6,615,171.22 in Q3 2023, reflecting a year-over-year increase of 513.5%[14] - Basic earnings per share for Q3 2024 were CNY 0.09, compared to CNY 0.02 in Q3 2023, indicating improved earnings performance[16] Assets and Liabilities - Total assets as of the end of Q3 2024 were ¥2,016,357,890.83, a 1.65% increase from the end of the previous year[2] - Total assets increased from 1,983,579,928.71 yuan to 2,016,357,890.83 yuan, an increase of approximately 1.6%[12] - Total liabilities as of the end of Q3 2024 were CNY 298,855,068.51, a slight decrease from CNY 306,587,803.58 at the end of Q3 2023[13] - The company's current liabilities decreased from 304,022,604.56 yuan to 296,775,845.55 yuan, a reduction of about 2.4%[12] - The non-current assets increased from 587,123,614.54 yuan to 746,580,570.41 yuan, an increase of approximately 27.1%[12] Cash Flow and Investments - The company's cash flow from operating activities showed a net outflow of ¥42,618,702.89 year-to-date, representing a 41.32% improvement compared to the same period last year[2] - Operating cash inflow for the period was CNY 242,670,080.38, an increase of 8.3% from CNY 222,797,200.50 in the previous period[17] - Net cash outflow from operating activities was CNY -42,618,702.89, improving from CNY -72,634,723.02 year-over-year[17] - Investment cash inflow totaled CNY 290,688,549.66, down 37.6% from CNY 466,946,395.57 in the previous period[18] - Net cash outflow from investment activities was CNY -485,191,729.93, compared to CNY -95,304,657.51 in the previous period, indicating increased investment expenditures[18] Expenses and Financial Performance - Research and development expenses increased by 42.61% year-over-year, indicating a commitment to innovation and product development[6] - Research and development expenses increased to CNY 13,189,202.84 in Q3 2024, up from CNY 9,248,335.89 in Q3 2023, highlighting the company's commitment to innovation[14] - The company reported a tax expense of CNY 5,097,794.55 for Q3 2024, compared to a tax benefit of CNY -1,103,808.65 in Q3 2023, indicating a shift in tax obligations[14] - The total operating costs for Q3 2024 were CNY 366,931,853.01, up from CNY 247,364,447.43 in the same period last year, reflecting increased operational activities[14] Shareholder Information - The total number of common shareholders at the end of the reporting period is 20,999[8] - Guangdong Nanhai Holding Group Co., Ltd. holds 25.71% of shares, totaling 123,426,733 shares[8] Inventory and Other Assets - The company's inventory decreased from 201,695,499.70 yuan to 185,389,371.44 yuan, a decline of about 8.1%[11] - The company's other current assets increased significantly from 1,370,638.10 yuan to 166,546,839.74 yuan, a growth of approximately 121.1%[11] - Accounts receivable increased from 376,059,589.48 yuan to 463,776,266.53 yuan, representing a growth of about 23.2%[11] Financial Position Changes - The company's cash and cash equivalents decreased from 733,491,500.71 yuan to 216,542,830.65 yuan, a decline of approximately 70.5%[10] - Cash and cash equivalents at the end of the period were CNY 182,538,660.53, down from CNY 465,060,890.35 at the end of the previous period[18] Management Changes - The company appointed two new vice presidents, Mr. Ren Gang and Ms. Wang Na, on August 28, 2024[9]
南风股份:关于收到中标通知书的公告
2024-09-18 11:08
证券代码:300004 证券简称:南风股份 公告编号:2024-021 南方风机股份有限公司 关于收到中标通知书的公告 本公司及其董事会全体成员保证公告内容真实、准确和完整,没有虚假记 载、误导性陈述或重大遗漏。 南方风机股份有限公司(以下简称"公司")于近日收到中广核工程有限公 司发出的中标通知书,公司被确认为"CW 项目 LOT150Ad 空调机组及换热器" 的中标方。现将具体情况说明如下: 一、中标项目主要内容 1、招标项目名称:CW 项目 LOT150Ad 空调机组及换热器 2、招标方:中广核工程有限公司 3、中标人:南方风机股份有限公司 4、中标金额合计:5,157.00万元 5、设备名称:核岛 HVAC 系统空调机组及换热器,包含设备的设计、制造、 清洁、包装、运输、文件、现场服务、消耗品和专用工具等。具体以招标文件规 定为准。 法定代表人:宁小平 类型:有限责任公司 注册资本:388,600 万元人民币 住所:深圳市大鹏新区鹏飞路大亚湾核电基地工程公司办公大楼 经营范围: 软件和信息技术、工程建设技术、质检技术的服务、咨询;经 济信息咨询;招标代理;经营进出口业务(法律、行政法规、国务院决定禁止 ...
南风股份(300004) - 南风股份投资者关系管理信息
2024-09-12 09:14
Group 1: Company Overview and Market Position - The company is a state-owned enterprise and is focused on systematic market value management, considering market conditions and internal capabilities [1] - The company does not currently have any acquisition plans [1] Group 2: Product Development and Sales - The safety-grade quick pneumatic isolation valve has passed expert evaluation and is expected to enter the market soon [1] - The promotion of heavy metal 3D printing technology has been slower than expected due to various internal and external factors [2] Group 3: Financial Performance and Future Plans - The company reported a profit of over 20 million in the first half of the year, with an annual profit target of over 40 million [2] - The company aims to enhance its operational capacity and profitability through refinancing and acquisitions while focusing on core business development [2]